Sevadar Foundation Inc. was founded by Dr. Gurpreet Singh Padda, MD, MBA, MHP. He signed the articles of incorporation as incorporator, and he funds the foundation.
His role here is Founder. This page does not list a board roster, an officer slate or a governance chart, because publishing one that has not been verified would be worse than publishing nothing. When there is a documented governance structure to describe, it will be described here and on the transparency pages.
Who is Dr. Gurpreet Singh Padda?
Dr. Gurpreet Singh Padda, MD, MBA, MHP is a physician in St. Louis. He is board-certified in anesthesiology, interventional pain management, addiction medicine, obesity medicine and pain medicine, and he holds an MBA and a master’s in health professions education. He practices interventional pain management and metabolic medicine.
That background is the reason this foundation exists in the shape it does. A pain physician who has spent a career at the point where opioid policy, addiction and untreated pain meet arrives at a specific set of conclusions about which harms are being missed — and all four of these divisions are versions of the same conclusion. The full biography →
One title correction, stated here because it is regularly gotten wrong. Dr. Padda is Chief Medical Officer of Valor Villages Inc. — a separate 501(c)(3) organization. He is not the chief medical officer of Valor Medica, and Valor Medica is not Valor Villages. The two organizations, kept apart →
In the press
- Dr. Gurpreet Singh Padda, MD: Diabetic Neuropathy Is Treated as One Nerve Problem; It Is Three Different Problems (EIN Presswire, November 14, 2026). Diabetic neuropathy, Dr. Padda argues on World Diabetes Day, is three separate problems sharing one name, and nerve conduction studies and EMG come first because a trapped nerve and one damaged by sugar can feel alike.
- Dr. Gurpreet Singh Padda, MD on Veterans Day: The System Solved the Prescription and Did Not Solve the Pain (EIN Presswire, November 11, 2026). Among veterans in VA care, 50 to 60 percent live with chronic pain, a figure Dr. Padda cites for Veterans Day, and he ties PTSD, pain and metabolic health together even when a veteran’s weight looks normal.
- Dr. Gurpreet Singh Padda, MD: Trial Suggests PRP May Delay Knee Replacement for Patients Already on the Surgical List (EIN Presswire, October 12, 2026). His release for World Arthritis Day presents PRP for knees already on the surgical list exactly as the trial’s authors framed it, a way to buy time before replacement, with no promise of regrown cartilage.
- Dr. Gurpreet Singh Padda, MD Puts the New Low-Carb Guideline to Work in Pain Care: Medicines Change Before Pain Does (EIN Presswire, October 7, 2026). Dr. Padda describes how he uses the October 2026 consensus guideline on carbohydrate reduction, in which every one of 18 statements passed a 70 percent threshold, to set baseline labs, electrolyte targets and medicine changes for people with chronic pain.
- Dr. Gurpreet Singh Padda, MD Publishes The Dopamine Brain: Dopamine Is Not the Pleasure Chemical We Thought (EIN Presswire, October 5, 2026). Volume four of his series, The Dopamine Brain, holds that dopamine steers wanting rather than enjoyment, and it traces the idea to a 1998 study in which animals without working dopamine still liked sweetness but quit seeking it.
- Dr. Gurpreet Singh Padda, MD Publishes ‘The Angry Gut, Your First Brain’ (EIN Presswire, September 28, 2026). At 492 pages, with 33 chapters that are each filmed and paired with free technical supplements, The Angry Gut argues that the nervous system of the gut evolved before the brain in the skull.
- Dr. Gurpreet Singh Padda, MD: Half of Diabetic Nerve Damage Causes No Symptoms, and It Still Causes Falls (EIN Presswire, September 24, 2026). Picked up by AP News and KRON 4 San Francisco, the Falls Prevention Awareness Week release explains how silent diabetic nerve damage can make its first appearance as a fall.
- Dr. Gurpreet Singh Padda, MD Publishes The Pained Brain, Arguing Chronic Pain Is a Metabolic Disease the Scan Cannot See (EIN Presswire, September 21, 2026). At $722.8 billion in U.S. costs each year, chronic pain should be counted in lives as well as lost work, The Pained Brain argues, with roots in the nervous system and in body-wide inflammation.
- Dr. Gurpreet Singh Padda, MD Discusses Alzheimer’s Research, Not Just Plaque (EIN Presswire, September 21, 2026). Starving rather than dead is how Dr. Padda describes brain cells in parts of the Alzheimer’s brain that run low on energy, since they keep taking up ketones even as their use of glucose falls by between a fifth and a quarter.
- International Overdose Awareness Day (EIN Presswire, August 31, 2026). Figures the practice issued on International Overdose Awareness Day, based on its own patients and not on trials, show that the average new patient had spent upward of 2.5 years in pain at daily doses above 90 morphine milligram equivalents.
- “First Year They Sleep”: Valor Villages Bets on Slow Repair, for Veterans With PTSD and for the Ground They Work (EIN Presswire, August 7, 2026). Valor Villages, where Dr. Padda serves as chief medical officer, began a horticulture retraining program built around quiet work, restored Missouri prairie covering two-tenths of an acre, and a green roof planned for the Woodson Road building.
- New Book The Starved Brain by Dr. Gurpreet Padda Reframes Dementia as a Metabolic Disease of Overnutrition (EIN Presswire, July 23, 2026). In his first book, Dr. Padda argues that dementia often grows out of overnutrition, a brain supplied with ample calories yet low on fats, cholesterol and the other nutrients that make up its structure, and he lays out a four-pillar prevention framework.
- FDA Advisory Committee Convenes on Peptides: Understanding What Reclassification Means (EIN Presswire, July 20, 2026). Before federal advisers met in July 2026 to review seven compounded peptides, Dr. Padda explained that pulling peptides off a restricted list made review possible but was never an approval or a safety finding.
- Patients Already on the Knee Replacement Waiting List Find Platelet-Rich Plasma Outperformed Cortisone and NSAIDs (EIN Presswire, July 19, 2026). Ninety people waiting for knee replacement, all with arthritis graded 3 or 4, took part in the randomized trial this release reports, where PRP injected twice a week apart outperformed one steroid injection and an anti-inflammatory taken daily.
- Padda Institute Center for Interventional Pain Management Relocates to Expanded State-of-the-Art Facility (EIN Presswire, March 1, 2026). This relocation puts Dr. Padda’s practice in Suite 100 at 4477 Woodson Road, a larger building where image-guided procedures are done outside a hospital and without hospital facility charges.
- Valor Villages Launches Capital Campaign to Create 24-Bed Home for Unhoused Children (EIN Presswire, February 18, 2026). Through its Building Bright Futures capital campaign, Valor Villages is raising money for a 24-bed residential home in St. Louis for children who are homeless or displaced, carrying the model it built for veterans housing to a new group.
- Valor Villages Receives $200,000 Boost Toward Launch of Sanctuary for Children in Crisis (EIN Presswire, January 16, 2026). With a $200,000 gift, the children’s sanctuary Valor Villages had planned became a funded project, putting seed money toward the $500,000 required to open a home for children in crisis a month ahead of its capital campaign.
- Valor Villages Opens Veterans Housing Facility in St. Louis to Combat Homelessness Among Heroes (EIN Presswire, November 3, 2025). Valor #1 Housing opened with The Hunt Foundation’s support as a home for eight formerly unhoused veterans, with women and men in separate units, medical care through Valor Medica and rides to their appointments.
Frequently asked questions
Who founded Sevadar Foundation?
Dr. Gurpreet Singh Padda, MD, MBA, MHP founded Sevadar Foundation Inc. He signed the articles of incorporation as incorporator, he funds the foundation, and his role is Founder. He is a St. Louis physician who practices interventional pain management and metabolic medicine.
What is Dr. Gurpreet Padda board-certified in?
He is board-certified in anesthesiology, interventional pain management, addiction medicine, obesity medicine and pain medicine. He also holds an MBA and a master’s in health professions education. His career sits where opioid policy, addiction and untreated pain meet, and that is why the foundation’s divisions look the way they do.
Is Dr. Padda the chief medical officer of Valor Medica?
No. Dr. Padda is Chief Medical Officer of Valor Villages Inc., a separate 501(c)(3) organization. Valor Medica is not Valor Villages, and he is not the chief medical officer of Valor Medica. The separate-organization page explains how the two organizations are kept apart.
Does Sevadar Foundation publish a board roster?
Not yet. This page lists no board roster, officer slate or governance chart, because publishing one that has not been verified would be worse than publishing nothing. When there is a documented governance structure, it will be described here and on the transparency pages.